Leading BMI OrganBank’s visionary efforts in perfusion technology, my focus is on advancing organ transplantation and groundbreaking ex vivo research. With a strategic approach and commitment to quality, my leadership at BMI has been instrumental in guiding our proprietary OrganBank™ technology toward FDA clearance. My tenure has seen the successful navigation of FDA EUA status for our SuppleVent™ device, a vital contribution during the COVID-19 pandemic.

Previously, as CEO of Industrial Hard Carbon, LLC, I leveraged my expertise in new business development to significantly impact the biomedical, aerospace, and automotive sectors with our advanced surface film technologies. At the helm of both organizations, my dedication to team building and quality control has fostered environments where innovation thrives, and stakeholder value is paramount. The teams I build are known for their high performance, a testament to our shared commitment to excellence and productivity.